Fabric Genomics

Executive Summary

Fabric Genomics is a pioneering bioinformatics company that leverages AI to accelerate the clinical interpretation of genomic data. Its platform integrates whole genome, exome, and panel analysis to produce actionable insights for diagnosing rare genetic diseases, addressing a critical bottleneck in precision medicine. The company also operates a CLIA/CAP-accredited laboratory, offering clinical testing services that complement its software solutions. By combining advanced computational tools with robust laboratory capabilities, Fabric Genomics empowers healthcare providers and lab partners to reduce diagnostic odysseys and improve patient outcomes. Founded in 2009 and headquartered in Oakland, California, the company has established itself as a key player in the rapidly growing genomics market, which is expected to exceed $60 billion by 2030. Despite its long history, Fabric remains private and has not disclosed funding, but its proven technology and clinical adoption position it well for continued expansion.

Upcoming Catalysts (preview)

• Q3 2026FDA clearance for expanded variant interpretation module70% success
• Q3 2026Strategic partnership with a top-10 U.S. hospital system for clinical deployment60% success
• TBDSeries C funding round led by healthcare-focused VC75% success